Clinical, serological and DNA testing in Bengo Province, Angola further reveals low filarial endemicity and opportunities for disease elimination [PDF]
The prevalence of Loa loa, Onchocerca volvulus and Wuchereria bancrofti infections in an under-surveyed area of Bengo Province, Angola, was determined by surveying 22 communities with a combination of clinical, serological and DNA diagnostics. Additional
Thomas R Unnasch +2 more
exaly +4 more sources
Loa loa and Mansonella perstans microfilaremia in the department of Lékoumou, Republic of Congo [PDF]
Background Loiasis is endemic in the northern and western part of the Republic of Congo. Between 2004 and 2010, surveys were conducted, using the RAPLOA method, in all departments of the Republic of Congo to assess the distribution of loiasis.
Michel Boussinesq +2 more
exaly +3 more sources
Validation of the rapid assessment procedure for loiasis (RAPLOA) in the democratic republic of Congo [PDF]
Background A simple method called RAPLOA, to rapidly assess what proportion of people in a community are infected with L. loa and hence which communities are at high risk of severe adverse reactions following ivermectin treatment, was developed in ...
Samuel Wanji +2 more
exaly +4 more sources
The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA) [PDF]
BackgroundLoiasis is a major obstacle to ivermectin treatment for onchocerciasis control and lymphatic filariasis elimination in central Africa. In communities with a high level of loiasis endemicity, there is a significant risk of severe adverse ...
Samuel Wanji +2 more
exaly +4 more sources
Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria [PDF]
Nigeria has the heaviest burden of lymphatic filariasis (LF) in sub-Saharan Africa, which is caused by the parasite Wuchereria bancrofti and transmitted by Anopheles mosquitoes. LF is targeted for elimination and the national programme is scaling up mass
David Molyneux +2 more
exaly +4 more sources
Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections. [PDF]
BackgroundThe parasitic disease loiasis is associated with significant morbidity and mortality. Individuals with hyper-microfilaremia (greater than 20,000 microfilariae per mL of blood) may suffer from serious treatment-related or spontaneous adverse ...
Luzia Veletzky +17 more
doaj +2 more sources
Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a Loa loa co-endemic area: The Angolan experience [PDF]
The Republic of Angola is a priority country for onchocerciasis and lymphatic filariasis (LF) elimination, however, the co-distribution of the filarial parasite Loa loa (loiasis) is a significant impediment, due to the risk of severe adverse events (SAEs)
Miguel Brito +9 more
doaj +2 more sources
Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria. [PDF]
BackgroundLoiasis is currently receiving attention as a disease of public health importance because of the possibility of increased risk of developing neurologic serious adverse event following mass ivermectin treatment against onchocerciasis in ...
Olusola Ojurongbe +9 more
doaj +2 more sources
Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping [PDF]
Background The wide distribution of Loa loa infection (loiasis) throughout the Democratic Republic of Congo (DRC) is a major obstacle to the plans to eliminate onchocerciasis and lymphatic filariasis (LF) because the standard drug regime is dependent on ...
Louise A Kelly-Hope +4 more
doaj +2 more sources
Loiasis remains a significant public health concern, particularly in regions co-endemic for onchocerciasis and lymphatic filariasis, where high Loa loa microfilaraemia increases the risk of Severe Adverse Events (SAE) following mass drug administration ...
Q. O. Adeshina +15 more
doaj +1 more source

